Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASND CVE:GRG CVE:IZN TSE:SVB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNDAscendis Pharma A/S$191.49+0.6%$174.03$111.09▼$199.99$11.64B0.41464,205 shs1.55 million shsGRGGolden Arrow ResourcesC$0.07+7.7%C$0.05C$0.04▼C$0.07C$11.23M1.1356,003 shs7,001 shsIZNInZinc MiningC$0.02-20.0%C$0.02C$0.02▼C$0.03C$2.47M3.7676,425 shs51,000 shsSVBSilver Bull ResourcesC$0.30+5.3%C$0.27C$0.11▼C$0.32C$9.99M0.7446,901 shs21,800 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNDAscendis Pharma A/S+0.60%+9.75%+8.98%+26.60%+54.90%GRGGolden Arrow Resources+7.69%+7.69%+40.00%+55.56%+40.00%IZNInZinc Mining0.00%0.00%-20.00%-20.00%0.00%SVBSilver Bull Resources+5.26%+5.26%-3.23%+71.43%+106.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASNDAscendis Pharma A/S3.4233 of 5 stars4.52.00.00.03.31.70.6GRGGolden Arrow Resources1.2681 of 5 stars3.50.00.00.00.01.70.0IZNInZinc MiningN/AN/AN/AN/AN/AN/AN/AN/ASVBSilver Bull ResourcesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNDAscendis Pharma A/S 3.00Buy$239.8025.23% UpsideGRGGolden Arrow Resources 3.00BuyC$0.21200.00% UpsideIZNInZinc Mining 0.00N/AN/AN/ASVBSilver Bull Resources 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IZN, ASND, SVB, and GRG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/8/2025ASNDAscendis Pharma A/SWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$289.00 ➝ $295.008/8/2025ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$243.00 ➝ $290.008/8/2025ASNDAscendis Pharma A/SRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$210.00 ➝ $230.008/8/2025ASNDAscendis Pharma A/SUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$306.00 ➝ $307.008/8/2025ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$212.00 ➝ $220.008/8/2025ASNDAscendis Pharma A/SCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $203.008/8/2025ASNDAscendis Pharma A/SStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$212.00 ➝ $254.007/29/2025ASNDAscendis Pharma A/SJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$245.00 ➝ $254.007/11/2025ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$213.00 ➝ $243.007/3/2025ASNDAscendis Pharma A/SMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$250.00(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNDAscendis Pharma A/S$393.54M29.75N/AN/A($1.88) per share-101.86GRGGolden Arrow ResourcesN/AN/AC$0.04 per share1.94C$0.01 per shareN/AIZNInZinc MiningN/AN/AC$0.02 per share1.20C$0.02 per shareN/ASVBSilver Bull ResourcesN/AN/AC$0.03 per share9.72C$0.12 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNDAscendis Pharma A/S-$409.12M-$6.28N/A797.88N/A-54.94%N/A-24.49%N/AGRGGolden Arrow Resources-C$6.83M-C$0.04N/A∞N/AN/A-152.41%-63.37%N/AIZNInZinc Mining-C$1.28MN/A2.00∞N/AN/A-16.50%-9.89%N/ASVBSilver Bull Resources-C$118.67K-C$0.01N/A∞N/AN/A-3.07%-2.41%N/ALatest IZN, ASND, SVB, and GRG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025ASNDAscendis Pharma A/S-$1.42-$0.93+$0.49-$0.93$163.17 million$216.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNDAscendis Pharma A/SN/AN/AN/AN/AN/AGRGGolden Arrow ResourcesN/AN/AN/AN/AN/AIZNInZinc MiningN/AN/AN/AN/AN/ASVBSilver Bull ResourcesN/A0.80%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNDAscendis Pharma A/SN/A1.040.71GRGGolden Arrow ResourcesN/A1.1715.33IZNInZinc MiningN/A26.5924.92SVBSilver Bull ResourcesN/A2.101.94Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNDAscendis Pharma A/SN/AGRGGolden Arrow ResourcesN/AIZNInZinc Mining3.24%SVBSilver Bull ResourcesN/AInsider OwnershipCompanyInsider OwnershipASNDAscendis Pharma A/S40.00%GRGGolden Arrow Resources7.82%IZNInZinc Mining20.14%SVBSilver Bull Resources9.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASNDAscendis Pharma A/S1,01761.15 million36.69 millionOptionableGRGGolden Arrow ResourcesN/A160.42 millionN/ANot OptionableIZNInZinc MiningN/A123.40 millionN/ANot OptionableSVBSilver Bull Resources333.30 millionN/ANot OptionableIZN, ASND, SVB, and GRG HeadlinesRecent News About These CompaniesSilver Bull Resources, Inc. (SVB.TO) - Yahoo Finance CanadaJuly 11, 2025 | ca.finance.yahoo.comSilver Bull Resources Provides Update On Its Arbitration Case Against MexicoApril 30, 2025 | juniorminingnetwork.comSilver Bull Resources Inc.October 24, 2024 | wsj.comEndeavour Silver Could Continue To Be Silver On SteroidsOctober 10, 2024 | seekingalpha.comIs Silver Poised to Outperform Gold in This Gold Bull Market?September 26, 2024 | moneymetals.comMNew Samsung EV battery technology has captivated silver bulls. Here’s the argument.August 23, 2024 | marketwatch.comClosing Bell: Silver Bull Resources Inc flat on Monday (SVB)July 31, 2024 | theglobeandmail.comClosing Bell: Silver Bull Resources Inc flat on Tuesday (SVB)May 21, 2024 | theglobeandmail.comArras Minerals Announces C$2 Million Non-Brokered FinancingMay 21, 2024 | finance.yahoo.comArras Minerals Announces Voting Results of Annual and Special Meeting of ShareholdersMay 1, 2024 | finance.yahoo.comStocks in play: Silver Bull Resources, Inc.April 19, 2024 | ca.finance.yahoo.comSilver Bull Resources, Inc.: SILVER BULL ANNOUNCES VOTING RESULTS OF ANNUAL MEETING OF SHAREHOLDERSApril 19, 2024 | finanznachrichten.deSilver: Long-Awaited Bull Move Finally Approaching As Inventories Dwindle?April 1, 2024 | seekingalpha.comA Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right NowMarch 23, 2024 | msn.comStocks in play: Silver Bull Resources, IncFebruary 27, 2024 | ca.finance.yahoo.comClosing Bell: Silver Bull Resources Inc flat on Wednesday (SVB)October 26, 2023 | theglobeandmail.comSilver Bull Secures US$9.5M Litigation Funding to Pursue Damages Claim Against the Mexican GovernmentSeptember 6, 2023 | finance.yahoo.comSilver Bull Resources: Top 10 Undervalued Basic Materials Sector Stocks on TSX (SVB)August 23, 2023 | theglobeandmail.comStocks in play: Silver Bull ResourcesJune 8, 2023 | ca.sports.yahoo.comSilver Bull Provides Update on Its US$178 Million Legacy NAFTA Claim Against MexicoJune 6, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIZN, ASND, SVB, and GRG Company DescriptionsAscendis Pharma A/S NASDAQ:ASND$191.49 +1.14 (+0.60%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$190.99 -0.50 (-0.26%) As of 08/8/2025 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.Golden Arrow Resources CVE:GRGC$0.07 +0.01 (+7.69%) As of 08/8/2025 10:05 AM EasternGolden Arrow Resources Corporation, a natural resource company, engages in the acquisition, exploration, and development resource properties in South America. The company explores for iron, copper, gold, cobalt, and silver deposits. Its flagship project is the 100% owned San Pietro Fe-Cu-Au-Co Project covering an area of 18,448 Ha located in Chile. Golden Arrow Resources Corporation was incorporated in 2015 and is based in Vancouver, Canada.Golden Arrow Resources Corporation operates as a subsidiary of Grosso Group Management Ltd.InZinc Mining CVE:IZNC$0.02 -0.01 (-20.00%) As of 08/8/2025 10:16 AM EasternInZinc Mining Ltd. acquires, explores for, and develops mineral properties in the United States and Canada. It primarily explores for zinc, copper, and indium deposits. The company holds a 100% interest in the Indy project comprising an area of 19,000 hectares located in Central British Colombia; and the West Desert Property located in Utah, the United States. The company was formerly known as Lithic Resources Ltd. and changed its name to InZinc Mining Ltd. in February 2014. InZinc Mining Ltd. was incorporated in 1997 and is headquartered in Vancouver, Canada.Silver Bull Resources TSE:SVBC$0.30 +0.02 (+5.26%) As of 08/8/2025 01:47 PM EasternSilver Bull Resources Inc is an exploration stage company engaged in acquiring and developing mineral properties. The company holds interests in various property concessions in Mexico within a mining district known as the Sierra Mojada District. The main project of the company is the Sierra Mojada Project. Its geographical segments are Mexico, Canada, and others. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down DraftKings Posts Record Quarter, Eyes Profitability Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
